TREATMENT OF MULTIPLE-SCLEROSIS WITH MITOXANTRONE

被引:62
作者
MAUCH, E
KORNHUBER, HH
KRAPF, H
FETZER, U
LAUFEN, H
机构
[1] Department of Neurology, Ulm University, Dietenbronn/Schwendi 1
关键词
MULTIPLE SCLEROSIS; THERAPY; IMMUNOSUPPRESSION; MITOXANTRONE; PILOT STUDY;
D O I
10.1007/BF02191555
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Ten multiple sclerosis patients, all with a rapid deteriorating disease profile, were treated with 12 Mg/M2 of the cytostatic agent mitoxantrone, administered every 3 months. This dosage is only 25% of what a patient with a solid tumour would normally receive during the same time period. In all treated patients the deterioration was stopped following the initial dosage; in four out of ten patients there was even an immediate improvement of the neurological status. Eight out of nine patients showed an improvement after 1 year as compared with their enrolment status; the other one remained stabile. In correlation with the clinical improvement, the mean P100 latencies of visual evoked potentials showed a reduction after 1 year. However, the changes identified through magnetic resonance imaging were even clearer than those seen clinically. At admission, this group of patients presented with a total of 169 gadolinium (Gd)-enhancing lesions. Only 10 lesions were enhancing in nine patients 12 months after the initiation of treatment. It appears that mitoxantrone accelerates the disappearance of Gd-enhancing lesions and prevents the development of new ones. Minimal side effects such as mild nausea and a slight faintness were evident in six patients and then for only 1-2 days.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 20 条
[1]  
[Anonymous], 1991, Lancet, V337, P441
[2]   SERIAL STUDY OF GADOLINIUM-DTPA MRI ENHANCEMENT IN MULTIPLE-SCLEROSIS [J].
BASTIANELLO, S ;
POZZILLI, C ;
BERNARDI, S ;
BOZZAO, L ;
FANTOZZI, LM ;
BUTTINELLI, C ;
FIESCHI, C .
NEUROLOGY, 1990, 40 (04) :591-595
[3]  
FIDLER JM, 1986, J IMMUNOL, V137, P727
[4]  
FIDLER JM, 1986, J IMMUNOL, V136, P2747
[5]  
FOG T, 1970, ACTA NEUROL SCAND, V46, P1
[6]  
GONSETTE RE, 1989, INT CONGR SER, V863, P161
[7]   MULTIPLE-SCLEROSIS - SERIAL STUDY OF GADOLINIUM-ENHANCED MR IMAGING [J].
GROSSMAN, RI ;
BRAFFMAN, BH ;
BRORSON, JR ;
GOLDBERG, HI ;
SILBERBERG, DH ;
GONZALEZSCARANO, F .
RADIOLOGY, 1988, 169 (01) :117-122
[8]  
GRUENER A, 1985, MITOXANTRON KLINISCH, P387
[9]   SERIAL GADOLINIUM-ENHANCED MAGNETIC-RESONANCE-IMAGING SCANS IN PATIENTS WITH EARLY, RELAPSING-REMITTING MULTIPLE-SCLEROSIS - IMPLICATIONS FOR CLINICAL-TRIALS AND NATURAL-HISTORY [J].
HARRIS, JO ;
FRANK, JA ;
PATRONAS, N ;
MCFARLIN, DE ;
MCFARLAND, HF .
ANNALS OF NEUROLOGY, 1991, 29 (05) :548-555
[10]  
Kappos L, 1988, J NEUROL, V235, P10